Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

X4 Pharmaceuticals (XFOR) Preferred Dividend Payments (2018 - 2019)

X4 Pharmaceuticals (XFOR) has disclosed Preferred Dividend Payments for 2 consecutive years, with $592000.0 as the latest value for Q1 2019.

  • For the quarter ending Q1 2019, Preferred Dividend Payments fell 20.0% year-over-year to $592000.0, compared with a TTM value of $592000.0 through Dec 2019, down 80.27%, and an annual FY2019 reading of $592000.0, down 80.27% over the prior year.
  • Preferred Dividend Payments was $592000.0 for Q1 2019 at X4 Pharmaceuticals, down from $756000.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $756000.0 in Q3 2018 and bottomed at $592000.0 in Q1 2019.